AKT1 and prostate cancer: For example, in prostate cancer, the upregulation of PP1γ can lead to a reduction in AKT phosphorylation, thereby inhibiting cancer cell proliferation and migration by disrupting glycolytic metabolism and altering lipid metabolism (30).